Statement of Changes in Beneficial Ownership (4)
03 Diciembre 2021 - 4:07PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Newman Mark |
2. Issuer Name and Ticker or Trading Symbol
Chemours Co
[
CC
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
President and CEO |
|
(Last)
(First)
(Middle)
C/O THE CHEMOURS COMPANY, 1007 MARKET STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
12/2/2021 |
|
(Street)
WILMINGTON, DE 19801
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Common Stock | 12/2/2021 | | M(1) | | 34252 | A | $18.45 | 179710.5795 (2) | D | |
| Common Stock | 12/2/2021 | | S(1) | | 34252 | D | $29.94 (3) | 145458.5795 (2) | D | |
| Common Stock | | | | | | | | 2480 | I | Reporting person's children |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Stock Option (Right to Buy) | $18.45 | 12/2/2021 | | M (1) | | | 34252 | (4) | 2/3/2022 | Common Stock | 34252 | $0 | 0 | D | |
| Explanation of Responses: |
| (1) | The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2021. |
| (2) | Includes directly owned shares, restricted stock units, and dividend equivalent units. |
| (3) | Shares were sold in multiple transactions at prices ranging from $29.51 to $30.16. |
| (4) | Option award was granted on February 4, 2015 with vesting in three equal annual installments beginning February 4, 2016. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Newman Mark
C/O THE CHEMOURS COMPANY
1007 MARKET STREET
WILMINGTON, DE 19801 | X |
| President and CEO |
|
Signatures
|
| /s/ Pauletta Brown, Attorney-in-Fact | | 12/3/2021 |
| **Signature of Reporting Person | Date |
Chemours (NYSE:CC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Chemours (NYSE:CC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
